Search
for
Sort by
Research 211–240 of 328
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- BH04 Growing interest: a survey of low-dose oral minoxidil prescribing for hair loss
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- Czy lek na jaskrę zrewolucjonizuje leczenie łysienia androgenowego? O repozycjonowaniu leku, którego efekt uboczny stał się pożądanym skutkiem terapii.
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- 499 Possible involvement of skin resident memory T cells in refractory alopecia areata
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- 26 Characterization of a murine model of aa induced by adoptive transfer of cultured lymph node cells
- Przewidywanie cech wyglądu człowieka na podstawie markerów DNA do celów medyczno-sądowych i kryminalistycznych
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- The use of dupilumab for the treatment of alopecia areata
- Dermal fibroblasts: the terminology, heterogeneity of subpopulations and common properties
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Evidence-Based Clinical Efficacy of Leukocyte and Platelet-Rich Fibrin in Maxillary Sinus Floor Lift, Graft and Surgical Augmentation Procedures
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases